OXMETIDINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H21N5O3S
Molecular Weight	399.467
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=C(CSCCNC2=NC=C(CC3=CC=C4OCOC4=C3)C(=O)N2)N=CN1

InChI

InChIKey=YTBDPHYVGACIPC-UHFFFAOYSA-N

InChI=1S/C19H21N5O3S/c1-12-15(23-10-22-12)9-28-5-4-20-19-21-8-14(18(25)24-19)6-13-2-3-16-17(7-13)27-11-26-16/h2-3,7-8,10H,4-6,9,11H2,1H3,(H,22,23)(H2,20,21,24,25)

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2861279 | https://www.ncbi.nlm.nih.gov/pubmed/2575788

Oxmetidine is an H2-receptor antagonist that was studied as a gastrointestinal agent. Oxmetidine possesses efficacy in the treatment of peptic ulcers. However, information about the further development of this drug is not available.

Approval Year

PubMed

Title	Date	PubMed
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.	2010-12	22272031
Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.	1990-03	1969477
Oxmetidine in the short term treatment of active duodenal ulcer. A review and commentary.	1989	2575788
Mechanism of oxmetidine (SK&F 92994) cytotoxicity in isolated rat hepatocytes.	1985-06	2861279

Sample Use Guides

In Vitro Use Guide

Oxmetidine (50 microM) blocked pyruvate/malate-supported state 3 (ADP-stimulated) respiration, caused a decrease in the ADP:0 ratio and a loss of respiratory control in isolated rat liver mitochondria.

Name

Type

Language

(1H)-PYRIMIDINONE, 5-(1,3-BENZODIOXOL-5-YLMETHYL)-2-((2-(((5-METHYL-1H-IMIDAZOL-4-YL)METHYL)THIO)ETHYL)AMINO)-

Preferred Name

English

OXMETIDINE

Official Name

English

oxmetidine [INN]

Common Name

English

2-((2-(((5-METHYLIMIDAZOL-4-YL)METHYL)THIO)ETHYL)AMINO)-5-PIPERONYL-4(1H)-PYRIMIDINONE

Systematic Name

English

Code System Code Type Description

CAS

72830-39-8